Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Forte Biosciences, Inc. | toca-ex311_7.htm |
| 10-K - 10-K - Forte Biosciences, Inc. | toca-10k_20191231.htm |
| EX-32.1 - EX-32.1 - Forte Biosciences, Inc. | toca-ex321_10.htm |
| EX-31.2 - EX-31.2 - Forte Biosciences, Inc. | toca-ex312_6.htm |
| EX-10.21 - EX-10.21 - Forte Biosciences, Inc. | toca-ex1021_197.htm |
| EX-10.20 - EX-10.20 - Forte Biosciences, Inc. | toca-ex1020_196.htm |
| EX-10.18 - EX-10.18 - Forte Biosciences, Inc. | toca-ex1018_540.htm |
| EX-10.12 - EX-10.12 - Forte Biosciences, Inc. | toca-ex1012_412.htm |
| EX-10.11 - EX-10.11 - Forte Biosciences, Inc. | toca-ex1011_383.htm |
| EX-10.10 - EX-10.10 - Forte Biosciences, Inc. | toca-ex1010_384.htm |
| EX-4.2 - EX-4.2 - Forte Biosciences, Inc. | toca-ex42_195.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-224880) of Tocagen Inc.,
(2) Registration Statement (Form S-8 No. 333-235852, 333-229963 and 333-223558) pertaining to the 2017 Equity Incentive Plan and the 2017 Employee Stock Purchase Plan of Tocagen Inc., and
(3) Registration Statement (Form S-8 No. 333-217300) pertaining to the 2009 Equity Incentive Plan, 2017 Equity Incentive Plan, and 2017 Employee Stock Purchase Plan of Tocagen Inc.;
of our report dated February 27, 2020, with respect to the financial statements of Tocagen Inc. included in this Annual Report (Form 10-K) of Tocagen Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
San Diego, California
February 27, 2020